BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4858216)

  • 1. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1974 Mar; 13(3):189-97. PubMed ID: 4858216
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
    Creese I
    Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
    Carlsson A; Engel J; Strömbom U; Svensson TH; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):117-28. PubMed ID: 4278296
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Oct; 24(1):8-24. PubMed ID: 4796448
    [No Abstract]   [Full Text] [Related]  

  • 7. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.
    Creese I; Iversen SD
    Psychopharmacologia; 1974; 39(4):345-57. PubMed ID: 4615333
    [No Abstract]   [Full Text] [Related]  

  • 9. Design of agents for stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ; Pinder RM
    J Pharm Pharmacol; 1974 Oct; 26(10):753-6. PubMed ID: 4156532
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 11. The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(2):117-33. PubMed ID: 4268638
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of L-histidine and chlorcyclizine on apomorphine-induced climbing behaviour and methamphetamine stereotypy in mice.
    Joshi VV; Balsara JJ; Jadhav JH; Chandorkar AG
    Eur J Pharmacol; 1981 Feb; 69(4):499-502. PubMed ID: 6113966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats.
    Ljungberg T; Ungerstedt U
    Physiol Behav; 1976 Mar; 16(3):277-83. PubMed ID: 1033572
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
    Cox B; Tha SJ
    Eur J Pharmacol; 1973 Oct; 24(1):96-100. PubMed ID: 4796449
    [No Abstract]   [Full Text] [Related]  

  • 15. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 16. Benzamide potentiation of behavioral apomorphine-induced effects; mechanism involved.
    Piriou F; Petit JY; Welin L
    Experientia; 1985 Nov; 41(11):1409-10. PubMed ID: 2998860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
    Jackson EA; Neumeyer JL; Kelly PH
    Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 19. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.